Suchergebnisse - (Subject:"Siltuximab")

PubPharm (121)

61

Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy

enthalten in: Journal of immunological methods | 2016

von Chen, F. | Teachey, D. | Pequignot, E. | +7

62

Deriving health utility values from a randomized, double-blind, placebo-controlled trial of siltuximab in subjects with multicentric Castleman's disease

enthalten in: Current medical research and opinion | 2016

von Vernon, M. | Robinson, D. | Trundell, D. | +3

63

Treatment of 14 cases of Castlemans disease : the experience of one centre and an overview of literature

enthalten in: Vnitrni lekarstvi | 2016

von Adam, Z. | Szturz, P. | Krejčí, M. | +16

64

Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma : an open-label phase I trial

enthalten in: Blood cancer journal | 2016

von Shah, J. | Feng, L. | Thomas, S. | +8

65

Siltuximab : a targeted therapy for idiopathic multicentric Castleman disease

enthalten in: Immunotherapy | 2016

von Fajgenbaum, D. | Kurzrock, R.

66

Siltuximab : A Review in Idiopathic (Human Herpesvirus-8-Negative) Multicentric Castleman Disease

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2015

von Lyseng-Williamson, K.

67

Plasmablastic microlymphoma arising in human herpesvirus-8-associated multicentric Castleman disease in a human immunodeficiency virus-seronegative patient with clinical response to anti-interleukin-6 therapy

enthalten in: Histopathology | 2015

von Koenig, G. | Stevens, T. | Peker, D.

68

A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman disease

enthalten in: Oncotarget | 2015

von van Rhee, F. | Casper, C. | Voorhees, P. | +7

69

Analysis of Inflammatory and Anemia-Related Biomarkers in a Randomized, Double-Blind, Placebo-Controlled Study of Siltuximab (Anti-IL6 Monoclonal Antibody) in Patients With Multicentric Castleman Disease

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2015

von Casper, C. | Chaturvedi, S. | Munshi, N. | +9

70

Clinical development of siltuximab

enthalten in: Current oncology reports | 2015

von Davis, C. | Shah, K. | Lechowicz, M.